João Durães

Dr. João Durães

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Epilepsy & Behavior
Verified
Journal Article
Closed access
MTMiguel Tábuas-Pereira
Miguel Tábuas-Pereira
JDJoão Durães
João Durães
JLJoana Lopes
Joana Lopes
FSFrancisco Sales
Francisco Sales
CBConceição Bento
Conceição Bento
ISIsabel Santana
Isabel Santana

13 August 2019 in Neurology
Verified
Journal Article
Closed access
PDF file
LCLouis Cousyn
Louis Cousyn
BLBruno Law-Ye
Bruno Law-Ye
NPNadya Pyatigorskaya
Nadya Pyatigorskaya
RDRabab Debs
Rabab Debs
RFRoseline Froissart
Roseline Froissart
YNYann Nadjar
Yann Nadjar
Objective To perform a systematic analysis and scoring of brain MRI white matter hyperintensities (WMH) in adult-onset Krabbe disease. Methods We retrospectively collected basic clinical data and the first available brain MRI from patients with confirmed Krabbe disease with first clinical manifestations beyond 10 years of age. Data were obtained from our reference center for lysosomal diseases (n = 6) and from contacted authors of published articles describing patients with adult-onset Krabbe disease (n = 15). T2-weighted fluid-attenuated inversion recovery images of each patient were analyzed and scored using a radiologic score of WMH in a single center. Results The corticospinal tract was always affected by WMH (100% of patients), however, with some distinctions along the tract: the precentral gyrus (100%), corona radiata (95%), and posterior internal capsule (81%) were highly abnormal, whereas the mesencephalon (57%), pons (52%), and medulla oblongata (5%) were less affected. WMH were also frequently present in the posterior lateral periventricular white matter (95%), optic radiations (86%), postcentral gyrus (71%), medial lemniscus (62%), and corpus callosum, especially in the isthmus (71%), whereas the genu was always normal. A few patients did not have the classical MRI pattern but extensive hyperintensities (n = 3), or patchy distribution of hyperintensities mimicking an acquired etiology (n = 2), or very subtle hyperintensities of the corticospinal tract (n = 1). Conclusions We specified the main locations of WMH, which were observed in the earliest stages of the disease and were also present in patients with atypical MRI pattern, highlighting the importance of radiologic features to guide the diagnosis.

20 March 2023 in European Journal of Neurology
Verified
Journal Article
Open access
ASAnuschka Spínola
Anuschka Spínola
MLMarisa Lima
Marisa Lima
MLMaria João Leitão
Maria João Leitão
CBCatarina Bernardes
Catarina Bernardes
JDJoão Durães
João Durães
IBInês Baldeiras
Inês Baldeiras
Background and purpose: Blood‐based biomarkers are promising tools for the diagnosis of Alzheimer disease (AD) at prodromal stages (mild cognitive impairment [MCI]) and are hoped to be implemented as screening tools for patients with cognitive complaints. In this work, we evaluated the potential of peripheral neurological biomarkers to predict progression to AD dementia and the relation between blood and cerebrospinal fluid (CSF) AD markers in MCI patients referred from a general neurological department.Methods: A group of 106 MCI patients followed at the Neurology Department of Coimbra University Hospital was included. Data regarding baseline neuropsychological evaluation, CSF levels of amyloid β 42 (Aβ42), Aβ40, total tau (t‐Tau), and phosphorylated tau 181 (p‐Tau181) were available for all the patients. Aβ42, Aβ40, t‐Tau, p‐Tau181, glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) levels were determined in baseline stored serum and plasma samples by commercial SiMoA (Single Molecule Array) assays. Progression from MCI to AD dementia was assessed at follow‐up (mean = 5.8 ± 3.4 years).Results: At baseline, blood markers NfL, GFAP, and p‐Tau181 were significantly increased in patients who progressed to AD at follow‐up (p < 0.001). In contrast, plasma Aβ42/40 ratio and t‐Tau showed no significant differences between groups. NfL, GFAP, and p‐Tau181 demonstrated good diagnostic accuracy to identify progression to AD dementia (area under the curve [AUC] = 0.81, 0.80, and 0.76, respectively), which improved when combined (AUC = 0.89). GFAP and p‐Tau181 were correlated with CSF Aβ42. Association of p‐Tau181 with NfL was mediated by GFAP, with a significant indirect association of 88% of the total effect.Conclusions: Our findings highlight the potential of combining blood‐based GFAP, NfL, and p‐Tau181 to be applied as a prognostic tool in MCI.

10 August 2021 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
ASAnuschka Silva‐Spínola
Anuschka Silva‐Spínola
MLMarisa Lima
Marisa Lima
MLMaria João Leitão
Maria João Leitão
JDJoão Durães
João Durães
MTMiguel Tábuas-Pereira
Miguel Tábuas-Pereira
IBInes Baldeiras
Ines Baldeiras

1 February 2017 in Neuroscience Letters
Verified
Journal Article
Closed access
AGAntónio José Gabriel
António José Gabriel
MAMaria Rosário Almeida
Maria Rosário Almeida
MRMaria Helena Ribeiro
Maria Helena Ribeiro
JDJoão Durães
João Durães
MTMiguel Tábuas-Pereira
Miguel Tábuas-Pereira
IBInes Baldeiras
Ines Baldeiras

9 August 2018 in Dementia and Geriatric Cognitive Disorders
Verified
Journal Article
Closed access
PDF file
JDJoão Durães
João Durães
MTMiguel Tábuas-Pereira
Miguel Tábuas-Pereira
RARui Araújo
Rui Araújo
DDDiana Duro
Diana Duro
IBInes Baldeiras
Ines Baldeiras
ISIsabel Santana
Isabel Santana
Background/Aims: The head turning sign (HTS) is frequently noticed in clinical practice, but few studies have investigated its etiological and neuropsychological correlates. Methods: The presence and frequency of the HTS was operationalized and prospectively evaluated in patients with Alzheimer’s disease (AD), amnestic mild cognitive impairment (MCI), and behavioral-variant frontotemporal dementia (bvFTD). Cerebrospinal fluid (CSF) samples for AD biomarkers were collected. Mini-Mental State Examination, Montreal Cognitive Assessment, Geriatric Depression Scale (GDS), and insight scale scores were ascertained. Results: A total of 84 patients were included. The HTS was more prevalent in AD than in MCI or bvFTD. It correlated negatively with cognitive measures and depression. It also had a positive correlation with CSF total tau and hyperphosphorylated tau proteins. Total tau protein and GDS score were the only variables independently associated with the HTS. Conclusions: The presence of the HTS in a cognitively impaired individual suggests a diagnosis of AD. A higher HTS frequency correlates with higher CSF total tau levels, a smaller GDS score, and worse cognitive measures. In the MCI subgroup, the HTS may suggest a higher risk of progression.